Login
Iridium Communications NASDAQ: IRDM
Offering voice and data connectivity through a constellation of 66 crosslinked LEO satellites, Iridium keeps people – and things – connected on the land, in the air, or at sea
| Name | Iridium Communications |
| Ticker | IRDM |
| Exchange | NASDAQ |
| Sector | Technology |
| Industry | Communications & Networking |
| Price | 40.61 |
| 52W Low/High | 17.91 / 54.37 |
| Market cap | 5.4 B |
| 1Y Total Return |
48.10%
Strong |
| 1Y Volatility |
60.73%
Average Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Offering voice and data connectivity through a constellation of 66 crosslinked LEO satellites, Iridium keeps people – and things – connected on the land, in the air, or at sea
Details
| Ticker | IRDM |
| Name | Iridium Communications |
| ISIN | US46269C1027 |
| CUSIP | 46269C102 |
| Exchange | NASDAQ |
| Sector | Technology |
| Industry | Communications & Networking |
| Country | USA |
| Currency | U.S. Dollar |
Share as of 2/24/21
| Close Price | 40.61 |
| 52W Low/High | 17.91 / 54.37 |
| Market cap | 5.4 B |
| 1Y Total Return |
48.10%
Strong |
| 1Y Volatility |
60.73%
Average Risk |
| Beta | 1.74 |
| PE (trailing) | - |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | -9.6% |
| Cash from Op. / Cur. Liabilities | 2.21 |
| Diluted Earnings / Share | -0.42 |
| ROE | - |
| ROIC | 0.1% |
| Price / Revenue | 9.3 |
| Price / Book | 3.8 |
| Price / CF | 21.7 |
| Current Ratio | 3.1 |
| Cur.Liabilities / Tot.Liabilities | 0.1 |
| Financial Leverage | 1.14 |
| in Mils USD |
rolling-year up to December
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
583
|
560
|
523
|
448
|
434
|
411
|
|
| Gross Profit |
441
|
415
|
380
|
323
|
324
|
310
|
|
| R&D |
12
|
14
|
22
|
15
|
16
|
16
|
|
| EBITDA |
308
|
195
|
253
|
238
|
225
|
125
|
|
| Operating Income |
35
|
10
|
42
|
101
|
176
|
74
|
|
| Net Income exc. Extra |
-
|
-
|
-
|
234
|
111
|
7
|
|
| per Share | |||||||
| Diluted avg Shares |
133
|
125
|
109
|
128
|
125
|
95
|
|
| EPS exc. Extra |
-0.42
|
-1.33
|
-0.22
|
1.82
|
0.89
|
-0.09
|
|
| Dividend |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
3,361
|
3,624
|
4,014
|
3,782
|
3,500
|
3,071
|
|
| Cash, Eq & Invt ShortTerm |
245
|
224
|
465
|
400
|
524
|
480
|
|
| Total Current Assets |
348
|
343
|
390
|
411
|
517
|
482
|
|
| Total Non-Current Assets |
3,013
|
3,281
|
3,624
|
3,371
|
2,983
|
2,589
|
|
| Intangibles |
46
|
47
|
49
|
50
|
46
|
47
|
|
| Total Liabilities |
1,942
|
2,164
|
2,413
|
2,186
|
2,156
|
1,842
|
|
| Total Current Liabilities |
113
|
114
|
263
|
214
|
83
|
102
|
|
| Long Term Debt |
1,828
|
2,051
|
2,150
|
1,971
|
2,073
|
1,741
|
|
| Shareholder equity |
1,419
|
1,459
|
1,602
|
1,596
|
1,344
|
1,229
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
250
|
198
|
264
|
260
|
225
|
217
|
|
| Depreciation |
303
|
298
|
218
|
122
|
49
|
52
|
|
| Cash from Investing |
-46
|
-128
|
-379
|
-373
|
-242
|
-439
|
|
| Capex |
39
|
118
|
391
|
400
|
406
|
495
|
|
| Cash from Financing |
-188
|
-313
|
194
|
17
|
224
|
202
|
|
| Stock Issued |
13
|
13
|
12
|
4
|
1
|
2
|
|
| Debt (LT) Issued |
-194
|
-285
|
220
|
22
|
251
|
230
|
|
| Free Cash Flow |
279
|
190
|
-114
|
27
|
-361
|
-413
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
-
|
-
|
-
|
48.7%
|
22.0%
|
-2.0%
|
|
| NCFO / Op.Income |
703.9%
|
1,957.9%
|
633.1%
|
256.3%
|
127.7%
|
294.7%
|
|
| Current Ratio |
3.1
|
3.0
|
1.5
|
1.9
|
6.2
|
4.7
|
|
| Financial Leverage D/E |
1.14
|
1.22
|
1.22
|
1.07
|
1.23
|
1.13
|
|
| Return on Capital Avg |
0.1%
|
5.4%
|
1.1%
|
6.2%
|
0.5%
|
1.2%
|
|
| Return on Shareholder Equity |
-
|
-
|
-
|
14.9%
|
7.4%
|
-0.7%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available